| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.4M | -28.5% |
| R&D Expense | $34.9M | +25.8% |
| SG&A Expense | $33.0M | +11.1% |
| Operating Income | -$66.5M | -19.8% |
| Income Tax | $0 | — |
| Net Income | -$83.8M | -33.8% |
| EPS (Basic) | -$0.07 | -16.7% |
| EPS (Diluted) | -$0.07 | -16.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.2M | +2.3% |
| Current Assets | $4.1M | -1.5% |
| Total Assets | $26.7M | -4.1% |
| Current Liabilities | $68.3M | +51.0% |
| Long-term Debt | $62.7M | +53.6% |
| Total Liabilities | $105.7M | +41.1% |
| Stockholders' Equity | -$94.5M | -43.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$57.0M | -6.3% |
| Investing Cash Flow | -$1.0M | +70.5% |
| Financing Cash Flow | $56.8M | +7.6% |